Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Inflation Reduction Act
Biotech
'By hook or crook': BIO CEO urges biotechs to persevere
Rachel King said few things would bring her out of retirement. Leading BIO just happened to be one of those things.
Gabrielle Masson
Oct 25, 2023 10:10am
IRA drives Relay to pause plans to win approval in rare cancer
Oct 13, 2023 6:45am
US price negotiations could hit R&D harder than expected: study
Sep 6, 2023 10:20am
'On our minds': Novartis, GSK mull IRA impact on R&D strategies
Jul 26, 2023 11:06am
Biotechs lobby for their identity as drug pricing reforms set in
Jun 28, 2023 7:00am
Bristol Myers reassessing portfolio in wake of IRA—report
Nov 21, 2022 11:00am